Patents Assigned to University of Central Florida Research Foundation, Ind.
  • Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
    Patent number: 8916199
    Abstract: The invention provides a method of treating ovarian cancer in a mammal, the method inhibits angiogenesis associated with the cancer and comprises the parenteral administration to the mammal of an effective amount of cerium oxide nanoparticles having a predominance of Ce+3.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: December 23, 2014
    Assignee: University of Central Florida Research Foundation, Ind.
    Inventors: Sudipta Seal, Ajay Karakoti, Vijayalakshmi Shridhar, Shailendra Giri